Can a wearable monitor prevent heart emergencies after valve replacement?

NCT ID NCT07739316

Not yet recruiting Disease control Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial tests whether wearing a portable heart monitor for two weeks after a TAVI procedure can reduce the risk of sudden death, dangerous heart rhythms, or stroke within the following year. People who have had a successful TAVI and show certain electrical abnormalities on their ECG at discharge may participate. Half will receive the monitor, while the other half will receive standard care, and outcomes will be compared.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ambulatory ECG monitoring device
What this could lead to: If effective, this approach could become standard care after TAVI, potentially reducing life-threatening heart rhythm complications.
What could go wrong: The trial is early and may not show a clear benefit. Extra monitoring could lead to unnecessary procedures or anxiety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis cardiac conduction defect

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC STENOSIS CONDUCTION DISTURBANCES

Contacts and locations

Locations

Institut universitaire de cardiologie et de pneumologie de Québec - UL

Québec, Quebec, G1Y 4G5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.